20 Results for "

glucose-dependent insulinotropic polypeptide (GIP) receptor

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "glucose-dependent insulinotropic polypeptide (GIP) receptor" in MCE Product Catalog:

26
26 Publications Verification
Cat. No.: HY-P1731C
Synonyms: LY3298176 sodium
Tirzepatide sodium (LY3298176 sodium) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide sodium exerts anti-apoptotic and pro-differentiation effects via the pAkt/CREB/BDNF cascade and miRNA in neurons; in the heart, it promotes BCAA catabolism and inhibits the mTOR pathway by mediating the dephosphorylation of BCKDHA; meanwhile, it effectively reduces insulin and leptin levels and suppresses inflammatory responses at the systemic level. Tirzepatide sodium can be used for research on myocardial infarction, colon cancer, diabetes, diabetic cognitive impairment, neurodegeneration, diabetes-related neuropathy, and obesity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2541A
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP (1-30) amide, porcine TFA is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42) . GIP (1-30) amide, porcine is a weak inhibitor of gastric acid secretion and potent stimulator of insulin.
loading...
    loading...
Cat. No.: HY-164535
CAS No.: 2887445-76-1
Synonyms: AMG 133
Maridebart cafraglutide (AMG 133) is a long-acting peptide-antibody conjugate that combines GLP-1 receptor agonist with glucose-dependent insulinotropic polypeptide (GIP) receptor antagonism. Maridebart cafraglutide shows antagonist activity against human, cynomolgus monkey and rat GIPR with IC50 values of 46.4 nM, 26.5 nM, 822.3 nM, respectively. Maridebart cafraglutide shows agonist activity against human, cynomolgus monkey, rat and mouse GLP-1R with EC50 values of 24.4 pM, 5.7 pM, 2.4 pM and 123 pM, respectively. Maridebart cafraglutide can be used for the study of obesity and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P10959
CAS No.: 2923558-68-1
Synonyms: LY3532226
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Macupatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide improves insulin secretion responses and insulin sensitivity.Macupatide can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P2542
CAS No.: 1802086-25-4
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo .
loading...
    loading...
Cat. No.: HY-P10959A
Synonyms: LY3532226 acetate
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Macupatide acetate is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Macupatide acetate improves insulin secretion responses and insulin sensitivity.Macupatide acetate can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P11321A
Synonyms: acyl-GIP hydrochloride
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

IUB0271 hydrochloride (acyl-GIP hydrochloride) is a glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist with blood-brain barrier permeability. IUB0271 hydrochloride activates the GIPR signaling pathway, inhibits food intake and weight gain, and induces cFos neuron activation in the area postrema. IUB0271 hydrochloride enhances lipid clearance and induces systemic fatty acid oxidation. IUB0271 hydrochloride improves dyslipidemia, reduces atherosclerotic plaque formation and decreases adipocyte volume. IUB0271 hydrochloride can be used in studies related to obesity, dyslipidemia and atherosclerosis .
loading...
    loading...
Cat. No.: HY-P11321
Synonyms: acyl-GIP
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

IUB0271 (acyl-GIP) is a glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist with blood-brain barrier permeability. IUB0271 activates the GIPR signaling pathway, inhibits food intake and weight gain, and induces cFos neuron activation in the area postrema. IUB0271 enhances lipid clearance and induces systemic fatty acid oxidation. IUB0271 improves dyslipidemia, reduces atherosclerotic plaque formation and decreases adipocyte volume. IUB0271 can be used in studies related to obesity, dyslipidemia and atherosclerosis .
loading...
    loading...
Cat. No.: HY-P2541
CAS No.: 134846-93-8
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42) . GIP (1-30) amide, porcine is a weak inhibitor of gastric acid secretion and potent stimulator of insulin.
loading...
    loading...
Cat. No.: HY-P1731CP
CAS No.: 2023788-19-2
Tirzepatide (LY3298176) (crude) is the crude form of Tirzepatide (HY-P1731).Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide exerts anti-apoptotic and pro-differentiation effects via the pAkt/CREB/BDNF cascade and miRNA in neurons; in the heart, it promotes BCAA catabolism and inhibits the mTOR pathway by mediating the dephosphorylation of BCKDHA; meanwhile, it effectively reduces insulin and leptin levels and suppresses inflammatory responses at the systemic level. Tirzepatide can be used for research on myocardial infarction, colon cancer, diabetes, diabetic cognitive impairment, neurodegeneration, diabetes-related neuropathy, and obesity .
loading...
    loading...
Cat. No.: HY-P702285
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Human
Source:  
E. coli Cell-free
loading...
    loading...
Cat. No.: HY-P702800
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P702801
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P702802
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P702803
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Cynomolgus
Source:  
P. pastoris
loading...
    loading...
Cat. No.: HY-P703990
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703685
Purity:  ≥ 95%, as determined by reducing Bis-Tris PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703965
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703982
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: GIPR; GIP-R; Gastric Inhibitory polypeptide receptor; PGQTL2; glucose-dependent insulinotropic polypeptide receptor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P0276F
Research Areas:  

Others

GIP, Cy5 labeled TFA is a Cy5-labeled gastric inhibitory polypeptide (GIP), which is specifically used to label endogenously/exogenously expressed glucose-dependent insulinotropic polypeptide receptor (GIPR) .
loading...
    loading...
  • 1